Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003793499 | SCV004581128 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2023-07-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004366589 | SCV005029256 | likely benign | Hereditary cancer-predisposing syndrome | 2023-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV004787022 | SCV005407029 | benign | Familial cancer of breast | 2024-09-03 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |